Clinical Trial Update: A Phase 1/2 Study of Repeated Intravenous E6011 Administration in Japanese Subjects With Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial summary for repeated IV administration of E6011 in Crohn's disease completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• E6011

Snippet

Sponsor: EA Pharma Co., Ltd. | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-01-30